Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TECH Bio-Techne | ABT Abbott Laboratories |
|---|---|---|
| Price | $72.33 -0.0% | $102.36 +0.3% |
| StockIQ Score | 60C+ Moderate Risk: Medium | 51C- Moderate Risk: Medium |
| Technical | 62C+ | 23F |
| Fundamental | 66B- | 72B |
| Growth | 62C+ | 45D+ |
| Fair Value | 33F | 38F |
| News | 98A+ | 92A+ |
| Quality | 42D | 63C+ |
| Risk | 56C | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Bio-Techne (TECH) outperforms Abbott Laboratories (ABT) in technical and growth scores, with 59 versus 50 and 62 versus 45, respectively. However, Abbott leads in fundamental scoring, at 72 compared to TECH’s 66. Valuation scores are closer, but TECH’s 33 is slightly lower than ABT’s 38. Both share a "MODERATE" rating.